Form 4 for SONM DNA X, Inc.
Accepted 2022-01-31 00:00:00 ET · period of report 2022-01-27 · accession 0000899243-22-003634 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-31 | 2022-01-27 | SONM | TIRVA ROBERT L. | Pres, CFO, COO | A - Grant | $0.00 | +233.6K | 339.4K | +221% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-27 | A | A | 233,638 | $0.00 | 339,378 | D | — | — | (F1) The amount of securities reported in this Form 4 as beneficially owned by the Reporting Person reflects adjustments made in connection with a 1-for-10 reverse stock split of the Issuer's common stock on September 15, 2021. (F2) Includes 1,250 shares of the Issuer's common stock that were purchased by the Reporting Person under the Issuer's employee stock purchase plan since the last filing of a Form 4 by the Reporting Person. |